These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8253870)

  • 1. Activation of the 92 kDa type IV collagenase by tissue kallikrein.
    Desrivières S; Lu H; Peyri N; Soria C; Legrand Y; Ménashi S
    J Cell Physiol; 1993 Dec; 157(3):587-93. PubMed ID: 8253870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
    Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
    Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
    Li L; Akers K; Eisen AZ; Seltzer JL
    Exp Cell Res; 1997 May; 232(2):322-30. PubMed ID: 9168808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of 92-kDa gelatinase B activity in the extracellular matrix by tissue kallikrein.
    Menashi S; Fridman R; Desrivieres S; Lu H; Legrand Y; Soria C
    Ann N Y Acad Sci; 1994 Sep; 732():466-8. PubMed ID: 7978840
    [No Abstract]   [Full Text] [Related]  

  • 6. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
    Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
    J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells.
    Qian X; Wang TN; Rothman VL; Nicosia RF; Tuszynski GP
    Exp Cell Res; 1997 Sep; 235(2):403-12. PubMed ID: 9299165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells.
    Lindstedt L; Kovanen PT
    Biochem Biophys Res Commun; 2000 Nov; 277(3):552-7. PubMed ID: 11061992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation.
    Uitto VJ; Airola K; Vaalamo M; Johansson N; Putnins EE; Firth JD; Salonen J; López-Otín C; Saarialho-Kere U; Kähäri VM
    Am J Pathol; 1998 Jun; 152(6):1489-99. PubMed ID: 9626053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 92- and 72-kilodalton type IV collagenases are elastases.
    Senior RM; Griffin GL; Fliszar CJ; Shapiro SD; Goldberg GI; Welgus HG
    J Biol Chem; 1991 Apr; 266(12):7870-5. PubMed ID: 1850424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage surface component gp160: sensitivity to plasmin and other proteases.
    Remold-O'Donnell E; Lewandrowski K
    J Immunol; 1982 Apr; 128(4):1541-4. PubMed ID: 6460805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation.
    Eeckhout Y; Vaes G
    Biochem J; 1977 Jul; 166(1):21-31. PubMed ID: 197917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in cervical cancer is mediated by HeLa metabolites through endothelial cell tissue kallikrein.
    Naidoo S; Raidoo DM
    Oncol Rep; 2009 Aug; 22(2):285-93. PubMed ID: 19578768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
    Rao CN; Mohanam S; Puppala A; Rao JS
    Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.
    Saunders WB; Bayless KJ; Davis GE
    J Cell Sci; 2005 May; 118(Pt 10):2325-40. PubMed ID: 15870107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.